Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (1-10 of 471) with videos related to

Pageof 48
Sort By:
Molecular Therapy Oncolytics|June 1, 2023
Radiovirotherapy at twentyDavid Dingli
Clinical Lymphoma, Myeloma & Leukemia|May 30, 2020
Venetoclax in a Patient With Light Chain Deposition Disease Secondary to MGRS That Progressed After Kidney TransplantationNelson Leung, David Dingli
Expert Review of Anticancer Therapy|July 24, 2004
Anagrelide: an update on its mechanisms of action and therapeutic potentialDavid Dingli, Ayalew Tefferi
Stem Cells (Dayton, Ohio)|August 26, 2006
Successful therapy must eradicate cancer stem cellsDavid Dingli, Franziska Michor
Leukemia & Lymphoma|July 16, 2005
A critical review of anagrelide therapy in essential thrombocythemia and related disordersDavid Dingli, Ayalew Tefferi
Current Hematologic Malignancy Reports|April 29, 2010
Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemiaDavid Dingli, Ayalew Tefferi
Blood|December 16, 2015
An unusual cause of ascitesLokesh K Jha, David Dingli
Cancer Biology & Therapy|April 2, 2008
Plasma membrane phospholipid labeling to estimate tumor burden and kineticsDavid Dingli, Val J Lowe
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|September 14, 2010
Modeling the architecture and dynamics of hematopoiesisDavid Dingli, Jorge M Pacheco
Stem Cell Reviews|January 8, 2008
Some dynamic aspects of hematopoietic stem cellsDavid Dingli, Jorge M Pacheco
Pageof 48

Showing results (1-10 of 471) with videos related to

Sort By:
Pageof 48
Molecular Therapy Oncolytics|June 1, 2023
Radiovirotherapy at twentyDavid Dingli
Clinical Lymphoma, Myeloma & Leukemia|May 30, 2020
Venetoclax in a Patient With Light Chain Deposition Disease Secondary to MGRS That Progressed After Kidney TransplantationNelson Leung, David Dingli
Expert Review of Anticancer Therapy|July 24, 2004
Anagrelide: an update on its mechanisms of action and therapeutic potentialDavid Dingli, Ayalew Tefferi
Stem Cells (Dayton, Ohio)|August 26, 2006
Successful therapy must eradicate cancer stem cellsDavid Dingli, Franziska Michor
Leukemia & Lymphoma|July 16, 2005
A critical review of anagrelide therapy in essential thrombocythemia and related disordersDavid Dingli, Ayalew Tefferi
Current Hematologic Malignancy Reports|April 29, 2010
Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemiaDavid Dingli, Ayalew Tefferi
Blood|December 16, 2015
An unusual cause of ascitesLokesh K Jha, David Dingli
Cancer Biology & Therapy|April 2, 2008
Plasma membrane phospholipid labeling to estimate tumor burden and kineticsDavid Dingli, Val J Lowe
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|September 14, 2010
Modeling the architecture and dynamics of hematopoiesisDavid Dingli, Jorge M Pacheco
Stem Cell Reviews|January 8, 2008
Some dynamic aspects of hematopoietic stem cellsDavid Dingli, Jorge M Pacheco
Pageof 48